| Treatment assignment | Relapse control | ||
---|---|---|---|---|
AS + PQ | AS-PYR + PQ | DHA-PP + PQ | ||
Subjects | 60 | 60 | 60 | 41 |
Withdrawals | 2 | 1 | 0 | 0 |
Relapses | 10 | 9 | 7 | 32 |
Efficacy by incidence density | ||||
Person-years at risk | 50.17 | 53.62 | 55.00 | 11.83 |
Relapse incidence density (attacks/person-yr) | 0.20 | 0.17 | 0.13 | 2.71 |
Efficacy (%) against relapse (95 % CI) | 92.2 (83.4 – 96.6) | 93.5 (85.7 – 97.3) | 95.0 (88.3 – 98.2) | na |
Efficacy by proportion relapse-free at 6Â months | ||||
Relapses within 6Â months | 10 | 7 | 7 | na |
% free of recurrence at 6 Months | 83 | 88 | 88 | na |